DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisone (Prednisone) - Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neutropenia (89)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 89   Next >>

Possible Prednisone side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-23

Patient: female, weighing 81.8 kg (180.0 pounds)

Reactions: Dyspnoea, Chest Pain, Pancytopenia, Pyrexia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1400 mg

Doxorubicin Hydrochloride
    Dosage: 94 mg

Prednisone
    Dosage: 375 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 700 mg

Vincristine Sulfate
    Dosage: 2 mg



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-08-22

Patient: male, weighing 55.2 kg (121.4 pounds)

Reactions: Unresponsive To Stimuli, Moaning, Neutropenia, Septic Shock, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mercaptopurine
    Start date: 2009-08-21

Methotrexate Sodium

Prednisone

Vincristine
    End date: 2012-08-10



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-08-22

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Tachycardia, Clostridium Difficile Colitis, Pancytopenia, Neutropenia, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 2780 mg

Doxorubicin Hydrochloride
    Dosage: 152 mg

Etoposide
    Dosage: 720 mg

Fluorine-18 2-Fluorou-2 Deoxyry-D-Glucose (18f-Fdg)
    Dosage: 12 mg

Prednisone
    Dosage: 1300 mg

Rituximab
    Dosage: 800 mg

Vincristine Sulfate
    Dosage: 3.6 mg



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07

Patient:

Reactions: Hospitalisation, Neuropathy Peripheral, Vomiting, Febrile Neutropenia, Neutropenia, Neutrophil Count Decreased, Lymphoma

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: for 5 days
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: for 5 days
    Indication: Diffuse Large B-Cell Lymphoma

Radiotherapy
    Indication: Diffuse Large B-Cell Lymphoma

Radiotherapy
    Indication: B-Cell Lymphoma

Rituximab
    Indication: B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Neupogen



Possible Prednisone side effects in 76 year old

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: 76 year old

Reactions: Lung Disorder, Neutropenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: daily for 5 days
    Indication: Diffuse Large B-Cell Lymphoma

Radiotherapy
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Neupogen



Possible Prednisone side effects in

Reported by a physician from United States on 2012-08-01

Patient:

Reactions: Nausea, Motor Dysfunction, Pain, Rash, Peripheral Sensory Neuropathy, Fatigue, Dyspepsia, Blood Potassium Decreased, Diarrhoea, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1
    Indication: Waldenstrom's Macroglobulinaemia

Cyclophosphamide
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Cyclophosphamide
    Dosage: on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Waldenstrom's Macroglobulinaemia

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Waldenstrom's Macroglobulinaemia

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Lymphocytic Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Dosage: maintenance
    Indication: Waldenstrom's Macroglobulinaemia

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Rituximab
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
    Indication: non-Hodgkin's Lymphoma

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: B-Cell Lymphoma

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: Lymphoma

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
    Indication: Lymphocytic Lymphoma

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: Waldenstrom's Macroglobulinaemia

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Waldenstrom's Macroglobulinaemia

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Lymphocytic Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: B-Cell Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Lymphoma

Other drugs received by patient: Diphenhydramine HCL; Acetaminophen; Ondansetron



Possible Prednisone side effects in 74 year old male

Reported by a physician from Mexico on 2012-08-01

Patient: 74 year old male, weighing 65.0 kg (143.0 pounds)

Reactions: Pulmonary Oedema, Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cabazitaxel
    Indication: Prostate Cancer
    Start date: 2012-04-04
    End date: 2012-04-04

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2012-04-04



Possible Prednisone side effects in

Reported by a physician from United Kingdom on 2012-08-01

Patient:

Reactions: Neutropenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1440 mg, unk
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: 96 mg, unk
    Indication: Mantle Cell Lymphoma

Prednisone
    Dosage: 100 mg, unk
    Indication: Mantle Cell Lymphoma

Prednisone
    Dosage: 80 unk, unk

Velcade
    Dosage: 3 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2011-01-27

Vincristine
    Indication: Mantle Cell Lymphoma

Other drugs received by patient: Sando K / 00031402 /



Possible Prednisone side effects in male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-01

Patient: male

Reactions: Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: B-Cell Lymphoma

Mabthera
    Indication: B-Cell Lymphoma

Prednisone
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-31

Patient:

Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: as part of abvd or beacopp
    Indication: Hodgkin's Disease

Chemoradiation
    Indication: Hodgkin's Disease

Cyclophosphamide
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: as part of abvd or beacopp
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Prednisone
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vincristine
    Indication: Hodgkin's Disease



Possible Prednisone side effects in male

Reported by a physician from Canada on 2012-07-30

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Platelet Count Decreased, Neutropenia, Altered State of Consciousness

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-04-16
    End date: 2012-04-23

Abiraterone Acetate
    Administration route: Oral
    Start date: 2012-04-27
    End date: 2012-04-29

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-04-02

Other drugs received by patient: Phosphate



Possible Prednisone side effects in female

Reported by a physician from United Kingdom on 2012-07-27

Patient: female, weighing 53.0 kg (116.6 pounds)

Reactions: Anaemia, Neutropenia, Hypokalaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Furosemide

Prednisone
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-26

Patient: female, weighing 50.6 kg (111.3 pounds)

Reactions: Nausea, Urinary Tract Infection, Cytomegalovirus Viraemia, Rhinorrhoea, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bactrim
    Indication: Prophylaxis

Mycophenolate Mofetil
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-16
    End date: 2011-06-04

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-08-24
    End date: 2011-05-16

Prednisone
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-10-23

Prograf
    Dosage: 4 mg am, 5 mg pm
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-12-09
    End date: 2011-05-16

Prograf
    Dosage: 2 mg, bid
    Administration route: Oral
    Start date: 2011-05-16

Other drugs received by patient: Losartan Potassium; Lasix



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-26

Patient:

Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: as part of abvd or beacopp
    Indication: Hodgkin's Disease

Chemoradiation
    Indication: Hodgkin's Disease

Cyclophosphamide
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: as part of abvd or beacopp
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Prednisone
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vincristine
    Indication: Hodgkin's Disease



Possible Prednisone side effects in

Reported by a physician from United Kingdom on 2012-07-25

Patient:

Reactions: Neutropenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1440 mg, unk
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: 96 mg, unk
    Indication: Mantle Cell Lymphoma

Prednisone
    Dosage: 80 unk, unk

Prednisone
    Dosage: 100 mg, unk
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: 3 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2011-01-27

Vincristine
    Indication: Mantle Cell Lymphoma

Other drugs received by patient: Sando K / 00031402 /



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-24

Patient: female, weighing 51.4 kg (113.1 pounds)

Reactions: Nausea, Urinary Tract Infection, Rhinorrhoea, Cytomegalovirus Viraemia, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bactrim
    Indication: Prophylaxis

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    End date: 2011-05-16

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Start date: 2011-05-16
    End date: 2011-06-04

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-08-24
    End date: 2011-05-04

Prednisone
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-10-23

Prograf
    Dosage: 4 mg am, 5 mg pm
    Administration route: Oral
    End date: 2011-05-16

Prograf
    Dosage: 2 mg, bid
    Administration route: Oral
    Start date: 2011-05-24

Prograf
    Dosage: 4 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-12-09

Prograf
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-16

Other drugs received by patient: Losartan Potassium; Lasix



Possible Prednisone side effects in

Reported by a physician from Italy on 2012-07-20

Patient:

Reactions: Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma Recurrent, Mucosal Inflammation, Neurotoxicity, Sepsis, Adverse Event, Cardiotoxicity, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Lymphoma, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2 on day 1 for chop and 750 mg/m2 on day 2 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: 50 mg/m2 on day 1 for chop and 50 mg/m2 on day 2 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 100 mg on days 1-5 for chop and r-chop
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 375 mg/m2 on day 1 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: 1.4 mg/m2 on day 1 for chop and 1.4 mg/m2 on day 2 for r-chop upto a maximum dose of 2 mg
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Neupogen



Possible Prednisone side effects in

Reported by a physician from United Kingdom on 2012-07-19

Patient:

Reactions: Neutropenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1440 mg, unk
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: 96 mg, unk
    Indication: Mantle Cell Lymphoma

Prednisone
    Dosage: 100 mg, unk
    Indication: Mantle Cell Lymphoma

Prednisone
    Dosage: 80 unk, unk

Velcade
    Dosage: 3 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2011-01-27

Vincristine
    Indication: Mantle Cell Lymphoma

Other drugs received by patient: Sando K / 00031402 /



Possible Prednisone side effects in male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-18

Patient: male

Reactions: Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide

Doxorubicin HCL

Mabthera
    Indication: B-Cell Lymphoma

Prednisone

Vincristine



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-18

Patient: female, weighing 59.1 kg (130.0 pounds)

Reactions: Abdominal Pain, Dehydration, Pancytopenia, Pyrexia, Neutropenia, Asthenia, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1250 mg

Doxorubicin Hydrochloride
    Dosage: 84 mg

Prednisone
    Dosage: 200 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 620 mg

Vincristine Sulfate
    Dosage: 2 mg



Possible Prednisone side effects in 80 year old male

Reported by a physician from India on 2012-07-16

Patient: 80 year old male, weighing 55.9 kg (123.0 pounds)

Reactions: Sepsis, Hypoglycaemia, Neutropenia, Cardiogenic Shock, Septic Shock, Pneumonitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cabazitaxel
    Indication: Prostate Cancer Metastatic
    Start date: 2011-09-08
    End date: 2011-09-08

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic

Other drugs received by patient: Dexamethasone; Granisetron; Lactulose; Avil; Vitamins with Minerals; Filgrastim; Antiseptics; Ranitidine; Ultracet; Chlordiazepoxide Hydrochloride / Clidinium Bromide; Metoclopramide; Crocin; Domstal



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-13

Patient:

Reactions: Neuropathy Peripheral, Neutropenia, Infection, Infusion Related Reaction

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Dosage: 6-821 day cycles; n=28
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Dosage: 6-821 day cycles; n=28

Obinutuzumab
    Indication: B-Cell Lymphoma

Prednisone
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-07-06

Patient: male, weighing 62.0 kg (136.4 pounds)

Reactions: Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 2177 mg

Doxorubicin Hydrochloride
    Dosage: 29 mg

Etoposide
    Dosage: 145 mg

Prednisone
    Dosage: 101 mg

Rituximab (Moab C2b8 Anti CD 20, Chimeric)
    Dosage: 630 mg

Vincristine Sulfate
    Dosage: .65 mg



Possible Prednisone side effects in

Reported by a physician from United States on 2012-07-05

Patient:

Reactions: Nausea, Anaemia, Chills, Constipation, Fatigue, Neuropathy Peripheral, Alopecia, Adverse Event, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide

Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1

Doxorubicin HCL
    Dosage: on day 1
    Indication: Chronic Lymphocytic Leukaemia

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia

Prednisone
    Dosage: on days 1-5
    Administration route: Oral

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: Chronic Lymphocytic Leukaemia

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: maintenance

Velcade
    Dosage: on days 1 and 8

Velcade
    Dosage: on days 1 and 8
    Indication: Chronic Lymphocytic Leukaemia

Velcade
    Dosage: on days 1 and 8
    Indication: B-Cell Lymphoma



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-05

Patient:

Reactions: Arrhythmia Supraventricular, Gastrointestinal Toxicity, Hypotension, Anaemia, Atrial Fibrillation, Cardiac Disorder, Disease Progression, Death, Neuropathy Peripheral, Cardiac Failure, Embolism, Sepsis, Atrioventricular Block, Neutropenia, Thrombocytopenia, Myocardial Infarction, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma
    Start date: 2006-04-01

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Prednisone
    Dosage: 60 milligram/sq. meter
    Indication: Multiple Myeloma
    Start date: 2006-04-01

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2006-04-01



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-05

Patient:

Reactions: Neurotoxicity, Cardiotoxicity, Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma



Possible Prednisone side effects in female

Reported by a physician from France on 2012-06-29

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Febrile Bone Marrow Aplasia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Start date: 2011-12-29

Doxorubicin Hydrochloride
    Start date: 2011-12-29

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma

Mabthera
    Start date: 2011-12-29
    End date: 2011-12-29

Mabthera
    Indication: Lymphoma

Neulasta
    Indication: Chemotherapy
    Start date: 2011-12-30
    End date: 2011-12-30

Prednisone
    Indication: non-Hodgkin's Lymphoma

Prednisone
    Start date: 2011-12-29

Vincristine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-12-29

Vincristine

Other drugs received by patient: Bisoprolol Fumarate



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-06-12

Patient: male, weighing 62.0 kg (136.4 pounds)

Reactions: White Blood Cell Count Decreased, Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 2177 mg

Doxorubicin Hydrochloride
    Dosage: 116 mg

Etoposide
    Dosage: 581 mg

Prednisone
    Dosage: 1008 mg

Rituximab (Moab C2b8 Andti Cd20, Chimeric)
    Dosage: 630 mg

Vincristine Sulfate
    Dosage: 2.69 mg



Possible Prednisone side effects in male

Reported by a physician from Spain on 2012-06-07

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-12

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-12

Prednisone
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-11

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-12

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-12



Possible Prednisone side effects in 74 year old male

Reported by a physician from Mexico on 2012-06-05

Patient: 74 year old male, weighing 65.0 kg (143.0 pounds)

Reactions: Pulmonary Oedema, Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cabazitaxel
    Indication: Prostate Cancer
    Start date: 2012-04-04
    End date: 2012-04-04

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2012-04-04



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017